NunaBio, a next-gen DNA manufacturing company, has secured £6.5 million in funding to scale-up its DNA platform and accelerate its continued growth as a commercially focused infrastructure business for synthetic biology, therapeutics, and research.
TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, will exhibit and present at The Pharma Days 2026, taking place 27-28th May at Palexpo in Geneva, Switzerland.
Ampersand Capital Partners, a private equity firm with deep operational expertise scaling life sciences and healthcare companies, announced it has completed the sale of Tjoapack to Alcami Corporation.
Vetter, a Contract Development and Manufacturing Organisation (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony.
Emerson has announced major advancements to the AspenTech Inmation OT Data Fabric, establishing it as the foundational enterprise-scale intelligence layer for the AspenTech Inmation Data Platform.
Hongene Biotech Corporation has announced its support of SiranBio’s SA1211 program, showing how Hongene works across different stages of developing and manufacturing structurally complex oligonucleotide therapeutics.
As the global pharmaceutical industry advances into a phase defined by innovation, automation, and deeper collaboration, CPHI & PMEC India 2026 has announced an expansion.
Exciva, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, has announced the appointment of Mark Altmeyer as chairman of its board of directors.
